Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis

Detalles Bibliográficos
Autores principales: Dhar, Sujan K., Sachdeva, Kartik, Das, Manjula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903900/
https://www.ncbi.nlm.nih.gov/pubmed/33676871
http://dx.doi.org/10.1016/j.dsx.2021.02.021
_version_ 1783654824035745792
author Dhar, Sujan K.
Sachdeva, Kartik
Das, Manjula
author_facet Dhar, Sujan K.
Sachdeva, Kartik
Das, Manjula
author_sort Dhar, Sujan K.
collection PubMed
description
format Online
Article
Text
id pubmed-7903900
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Diabetes India. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-79039002021-02-25 Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis Dhar, Sujan K. Sachdeva, Kartik Das, Manjula Diabetes Metab Syndr Article Diabetes India. Published by Elsevier Ltd. 2021 2021-02-24 /pmc/articles/PMC7903900/ /pubmed/33676871 http://dx.doi.org/10.1016/j.dsx.2021.02.021 Text en © 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Dhar, Sujan K.
Sachdeva, Kartik
Das, Manjula
Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis
title Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis
title_full Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis
title_fullStr Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis
title_full_unstemmed Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis
title_short Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis
title_sort inflammation and hypercoagulopathy are predominant risk factors of severity in covid-19 patients with diabetes mellitus: summary of a meta-analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903900/
https://www.ncbi.nlm.nih.gov/pubmed/33676871
http://dx.doi.org/10.1016/j.dsx.2021.02.021
work_keys_str_mv AT dharsujank inflammationandhypercoagulopathyarepredominantriskfactorsofseverityincovid19patientswithdiabetesmellitussummaryofametaanalysis
AT sachdevakartik inflammationandhypercoagulopathyarepredominantriskfactorsofseverityincovid19patientswithdiabetesmellitussummaryofametaanalysis
AT dasmanjula inflammationandhypercoagulopathyarepredominantriskfactorsofseverityincovid19patientswithdiabetesmellitussummaryofametaanalysis

Ejemplares similares